Sonova Aims for 7.6 Billion Dollars in Revenue by 2031

The hearing aid maker expects annual sales growth of 5 to 10 percent. It aims to reach 6 billion Swiss francs in revenue by the 2030/31 financial year end.

Xurve View
洞察:

The global hearing aid industry leader, SONOVA HOLDING AG-REG, has outlined a new strategic roadmap aimed at securing robust financial performance through the end of the decade. Headquartered in Switzerland, the company is adapting its operations to counter a slowing market and rising competitive threats under the direction of its recently appointed management team. In its latest medium-term guidance, the manufacturer projected that annual sales will grow at a rate of 5% to 10% in local currencies. These projections are part of a broader ambition to reach 6 billion Swiss francs, or roughly $7.6 billion, in total revenue by the 2030/31 financial year. Beyond top-line growth, Sonova is focusing on enhancing its profitability. The company expects its core operating profit to expand by 7% to 12% annually during this period. This outlook reflects the firm's efforts to streamline operations and leverage its scale as it faces a more challenging macroeconomic environment for medical devices.

IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。